Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million

Eurobio Scientific SA

11/10/2023 17:56

Oct 11 (Reuters) - Eurobio Scientific SA  ALERS.PA :
    * RESULTS FOR FIRST HALF OF 2023
    * INCREASED INTERNATIONALIZATION, WITH 35% OF SALES
GENERATED
OUTSIDE FRANCE
    * H1 GROSS MARGIN MAINTAINED AT A HIGH LEVEL (46.5% VERSUS
48.5%)
    * EUROBIO SCIENTIFIC RECORDED H1 SALES OF EUR 59.2M IN FIRST
HALF
OF 2023 FROM ITS CORE BUSINESS
    * H1 EBITDA REACHED EUR 13.4M, GIVING AN EBITDA MARGIN OF
23%
    * GENERATED OPERATING CASH FLOW OF EUR 11.4M IN 1ST HALF,
REPRESENTING A CASH CONVERSION RATIO OF 85% OF EBITDA

Source text for Eikon:  ID:nGNE1lVCfm 
Further company coverage:  ALERS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))